Biologics—medications derived from a biological source—are increasingly used as
pharmaceuticals, for example, as vaccines. Biologics are usually produced in bacterial …

Abstract This Progress Report reviews recent progress in applying electrospun nanofibers to
the emerging field of regenerative medicine. It begins with a brief introduction to …

In this review the current knowledge of protein degradation during preparation, storage and
release from poly (lactic-co-glycolic acid)(PLGA) microparticles is described, as well as …

Controlled release drug delivery employs drug-encapsulating devices from which
therapeutic agents may be released at controlled rates for long periods of time, ranging from …

Three-dimensional (3D) microstructures created by microfabrication and additive
manufacturing have demonstrated value across a number of fields, ranging from …

Gene silencing by Polycomb complexes is central to eukaryotic development. Cold-induced
epigenetic repression of FLOWERING LOCUS C (FLC) in the plant Arabidopsis provides an …

We report a new process of making highly-porous large polymeric microparticles for local
drug delivery to the lungs by inhalation. Poly (lactic-co-glycolic acid)(PLGA) microparticles …

The better understanding of endogenous proteins, peptides, and peptidergic molecules and
their role in various body functions and pathological conditions in last few decades has …

The effect of emulsification of lysozyme solutions with methylene chloride on protein
recovery and structural integrity was investigated. Total lysozyme recovery in the aqueous …

With advances in biotechnology, genomics, and combinatorial chemistry, a wide variety of
new, more potent and specific therapeutics are being created. Because of common …